Purchase Order N0017317P1084

The Office of Naval Research (ONR) awarded a $3,830.85 firm fixed price purchase order to Genscript USA Inc. on June 17, 2016, for protein services with an ultimate completion date of July 21, 2016. The contract, which was not set aside for small businesses, will be performed at the contractor's facility in Piscataway, New Jersey. Genscript USA Inc., a biotechnology company specializing in advanced molecular biology services, was selected to provide these protein-related services in support of...

The Office of Naval Research awarded a Purchase Order valued at $6,888.98 to Genscript USA Inc. on September 19, 2014, with completion targeted for December 31, 2014. This firm fixed-price contract was issued without a set-aside designation and involves protein-related products or services to be performed at the contractor's facility in Piscataway, New Jersey. Genscript USA Inc., a biotechnology company specializing in advanced molecular biology services, was selected to support the Navy's...

The Office of Naval Research awarded a firm fixed-price purchase order valued at $3,477.08 to Genscript USA Inc. for DNA sequencing services. The contract, which was not set aside for small businesses, was awarded on August 8, 2014, with an ultimate completion date of August 29, 2014. The work was performed at Genscript's facility in Piscataway, New Jersey, where the company maintains its headquarters and core operations in advanced molecular biology services. Genscript USA Inc. is a...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for custom peptide synthesis on September 13, 2018, with a ceiling value of $17,503.39.</p> <p>Work is performed in Piscataway, New Jersey. The order is firm fixed price with an ultimate completion date of October 31, 2018. No set-aside category applies.</p>

The U.S. government awarded Genscript USA Inc. a $6,582.14 firm fixed-price purchase order on September 12, 2016, for custom peptide synthesis and purification services. The contract, with an ultimate completion date of October 14, 2016, was funded by a civilian agency within the Pacific West Area and performed at the vendor's facility in Piscataway, New Jersey. No small business set-aside designation was applied to this award. Genscript USA Inc. is a biotechnology company specializing in...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. for custom peptide synthesis on June 16, 2018, with a ceiling value of $16,246.79. Work is performed in Piscataway, New Jersey. The order carries firm fixed pricing and no small business set-aside. Ultimate completion is scheduled for June 15, 2019.</p>

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. valued at $3,964.20 on September 5, 2017, for peptide services. Work is performed in Piscataway, New Jersey. The order carries a firm fixed price structure and ultimate completion date of October 5, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $3,666.96 on June 28, 2017. Performance occurs in Piscataway, New Jersey. The order procures peptide services on a firm fixed price basis, with ultimate completion targeted for July 27, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for peptide services valued at $7,701.00 on July 11, 2017. Place of performance is Piscataway, New Jersey. The order is firm fixed price with an ultimate completion date of August 9, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for peptide services on August 17, 2017, with a ceiling value of $8,353.96 and an ultimate completion date of September 30, 2017. Work is performed in Piscataway, New Jersey. The order is a firm fixed price purchase order with no set-aside.</p>